Expect to Hear About Renal Protection With Flozins and GLP-1 Agonists

You'll hear buzz about using SGLT2 inhibitors (Jardiance, etc) or GLP-1 agonists (Victoza, etc) to protect the kidneys in type 2 diabetes.

We know ACE inhibitors or ARBs slow progression of nephropathy in diabetes patients with hypertension and albuminuria.

Now data suggest Jardiance (empagliflozin) or Invokana (canagliflozin) may have some kidney protective effects...probably by lowering intraglomerular pressure.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote